Journals / Klinik Psikofarmakoloji Bülteni / 2009 / Cilt: 19 - Sayı: 4

Naltrexone treatment of self-injurious behavior in autistic patients and two case reports

Otistik hastalarda kendine zarar verme davranışında naltrekson tedavisi ve iki olgu sunumu

Pages
431–435
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Regarding two cases who are admitted to our inpatient unit, the effects of opiate antagonists as well as their neurobiological mechanisms which lower agression and other potential pharmocological indications were discussed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Opiates lower the excitation of locus coeruleus via decreasing the firing activity of neurons.
📊
Key Findings & Data:Increased brain opiatergic activity during neonatal period might decrease social motivation and cause social withdrawal in autistic children.
💡
Conclusion & Impact:Regarding two cases who are admitted to our inpatient unit, the effects of opiate antagonists as well as their neurobiological mechanisms which lower agression and other potential pharmocological indications were discussed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Opiates lower the excitation of locus coeruleus via decreasing the firing activity of neurons. It is implicated that dysfunction of opiatergic systems might be mostly responsible for causing social withdrawal behaviour. Increased brain opiatergic activity during neonatal period might decrease social motivation and cause social withdrawal in autistic children. Painful stimulants in post travmatic stress disorder patients increase opiate synthesis in brain and repetetive painful stimulants and şashbacks might reinforce this neurobiological process. Naltrexone, an opiate antagonist, is shown to decrease the şashbacks in patients with posttraumatic stress disorder. The underlying mechanism in which opiate antagonists diminish the self injurious behaviour in autistic children might involve the reduction of opiatergic activity which is increased by painful stimuli and self injurious behaviours. Regarding two cases who are admitted to our inpatient unit, the effects of opiate antagonists as well as their neurobiological mechanisms which lower agression and other potential pharmocological indications were discussed

Özet

Opiatlar lokus seruleusta ateşlenme hızını düşürerek uyarılmayı azaltırlar. Bu nedenle sosyal kaçınma ve geri çekilme davranışlarında opiaterjik sistem aktivasyonunun sorumlu olduğu ileri sürülmektedir. Otistik bozuklukta neonatal dönemde artmış beyin opiat aktivitesinin sosyal motivasyonu azaltarak otistik izolasyon ve uzaklaşmaya yol açtığı düşünülmektedir. Travma geçirmiş kişilerde ve Travma Sonrası Stres Bozukluğu (TSSB) olan hastalarda ağrılı uyaranın beyinde endojen opiat sentezini arttırdığı ve tekrarlayan ağrılı uyaranların veya geri dönüşlerin (şashback) bir pekiştirme kısırdöngüsü yarattığı ileri sürülmüştür.Opiat antagonisti naltreksonun travma sonrası stres bozukluğu hastalarında şash backleri azalttığı gösterilmiştir. Otistik çocuklarda kendine zarar verme davranışının opiat antagonistleri ile azaltılmasının altında yatan nörobiyolojik mekanizma da bu ağrılı uyaranlar (kendine zarar verme şeklinde) yoluyla artan endojen opiat aktivitesine bağlı kısır döngünün kırılması yoluyla olabilir. Kliniğimizde yatarak gözlem altına alınan ve naltrekson sonrasında kendine zarar verme davranışında azalma olan iki olgu bağlamında opiat antagonistlerinin bu alandaki etkileri ve olası nörobiyolojik mekanizmaları ile diğer potansiyel kullanım alanları tartışılacaktır

🔖

Cite This Article

ODABAŞIOĞLU, G., ÖZTÜRK, Ö., GENÇ, Y. (2022). Naltrexone treatment of self-injurious behavior in autistic patients and two case reports. Klinik Psikofarmakoloji Bülteni, Cilt: 19 - Sayı: 4, 431–435. https://ajindex.com/articles/574260

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mathew SJ, Coplan JD, Gorman JM. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry. 2001
  2. 1567 2. Smalley SL, McCracken J, Tanguay P. Autism, affective disorders and social phobia. Am J Med Genet 1995
  3. 26 3. Stigler KA, McDougle CJ. Child Adolesc Psychiatr Clin N Am. Pharmacotherapy of irritability in pervasive developmental disorders. 2008
  4. 752 4. Minshawi NF. Child Adolesc Psychiatr Clin N Am. Behavioral assessment and treatment of self-injurious behavior in autism. 2008
  5. 886 5. Parikh MS, Kolevzon A, Hollander E.J Child Adolesc Psychopharmacol. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. 2008
  6. 178 6. Mandell DS. J Autism Dev Disord. Psychiatric hospitalization among children with autism spectrum disorders. 2008
  7. 1065 7. McDougle CJ, Stigler KA, Erickson CA, Posey DJ.J Clin Psychiatry. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. 2008
  8. 69 Suppl 4:S15-S20 8. Walters AS, Barrett RP, Feinstein C, Mercurio A, Hole WT. J Autism Dev Disord. A case report of naltrexone treatment of self- injury and social withdrawal in autism. 1990
  9. Cazzullo AG, Musetti MC, Musetti L, Bajo S, Sacerdote P, Panerai A.Eur Neuropsychopharmacol. Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. 1999
  10. 366 10. Deutsch SI. Am J Ment Defic. Rationale for the administration of opiate antagonists in treating infantile autism. 1986
  11. 635 11. Stachnik JM, Nunn-Thompson C. Ann Pharmacother. Use of atypical antipsychotics in the treatment of autistic disorder. 2007
  12. 634 13. Krug DA, Arick JR, Almond PA. Autism Screening Instrument for Educational Planning. (1993), Pro-ed Inc. Austin Texas. 14. Piven J, Palmer P. Psychiatric disorder and broad autism phenotype: evidence from a family study of multiple-incidence autism families. Am J Psychiatry 1999, 156:557-563 15. Van der Kolk BA, Greenberg M, Boyd H, Krystal J. Inescapable shock, neurotransmitters, and addiction to trauma: toward a psychobiology of posttraumatic stress. Biol Psychiatry 1985
  13. 325 16. Coid J, Alloliao B, Rees LH. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1993
  14. 546 17. Pitman RK, Van der kolk BA, Orr SP. Naloxone-reversible analgesic response to combat-related posttra